Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

Boston Scientific recalls premixed embolic agent after two deaths
There have been a total of 11 incidents so far, including seven injuries and two deaths. Boston Scientific said the agent can still be used if operators follow specific instructions during lower GI bleed embolization procedures.
Cardiology, radiology groups urge insurance provider to rethink imaging policy
SCAI and four other major healthcare organizations signed a joint letter in support of intravascular ultrasound.
Interventional techniques can help limit amputations among CLI patients
Kumar Madassery, MD, detailed some of the techniques and tools used to restore blood flow to the foot to help foot wounds heal and prevent amputation.
Peripheral artery disease is out of control in many rural, low income communities
Peripheral artery disease (PAD) leads to more than 400 leg amputations per day in the U.S. Kumar Madassery, MD, discussed the importance of increasing awareness and reaching patients before it is too late.
Cardiologists, radiologists and surgeons push for increased adoption of IVUS during peripheral vascular interventions
Increasing the use of intravascular ultrasound when performing lower-extremity revascularization procedures could limit complications and improve patient outcomes, according to new recommendations from several medical societies.

Using isosmolar contrast agent during angioplasty reduces risk of renal and cardiac events, say data from GE Healthcare supported study

Significantly fewer renal and cardiac events are associated with angioplasty procedures using isosmolar contrast medium (IOCM) agent Visipaque (iodixanol) than those using low-osmolar contrast media (LOCM), demonstrate data from abstracts presented today at the EuroPCR Congress 2015 in Paris.

May 20, 2015

REVA Announces First Clinical Results From ReZolve2 Trial

REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") announced initial clinical results from patients treated with its ReZolve2 sirolimus-eluting bioresorbable coronary scaffold at Transcatheter Therapeutics 2013 ("TCT"), the world's leading interventional cardiology conference, which is being held this week in San Francisco, California. The ReZolve2 trial is currently enrolling up to 125 patients at multiple centers in Australia, Brazil, Europe, and New Zealand to provide the data needed to apply for European CE Marking. Patient enrollment was initiated in March 2013 and is currently ongoing.

October 29, 2013

Around the web

Cardiovascular Business

AI improves CT assessments, boosts care for real-world heart patients

Automated AI-generated measurements combined with annotated CT images can improve treatment planning and help referring physicians and patients better understand their disease, explained Sarah Jane Rinehart, MD, director of cardiac imaging with Charleston Area Medical Center.

Cardiovascular Business

AI predicts cardiovascular risk during CT scans—no invasive tests or contrast required

Two advanced algorithms—one for CAC scores and another for segmenting cardiac chamber volumes—outperformed radiologists when assessing low-dose chest CT scans.

Radiology Business

Google teams with Bayer to address radiologist burnout via AI

"Gen AI can help tackle repetitive tasks and provide insights into massive datasets, saving valuable time," Thomas Kurian, CEO of Google Cloud, said Tuesday.

Interventional Cardiology

Boston Scientific recalls premixed embolic agent after two deaths

Cardiology, radiology groups urge insurance provider to rethink imaging policy

Interventional techniques can help limit amputations among CLI patients

Peripheral artery disease is out of control in many rural, low income communities

Cardiologists, radiologists and surgeons push for increased adoption of IVUS during peripheral vascular interventions

Around the web